4
Clinical Trials associated with Thymosin alpha 1(Beijing SL Pharmaceutical Co., Ltd.)An Open Label, Multi-Center, Randomized, Two Arm, Phase III Clinical Trial toEvaluate Efficacy and Safety of Thymosin alpha one plus Standard of Care (SOC) in Comparisonwith SOC Alone in Patients with Confirmed Endometriosis
/ RecruitingEarly Phase 1IIT A prospective, randomized controlled trial of oral prednisone combined with thymosin 1 in recurrent adult patients with minimal lesions nephrotic syndrome
/ Not yet recruitingNot Applicable A PILOT, RANDOMIZED, SINGLE SITE, 3 PARALLEL ARMS, OPEN-LABEL STUDY IN PATIENTS ON CHRONIC DIALYSIS WITH END STAGE RENAL DISEASE (ESRD) TO EVALUATE THE ENHANCING EFFECT OF TWO DOSES OF THYMOSIN ALPHA 1 ON THE IMMUNOGENICITY OF EGG-DERIVED H1N1sw MONOVALENT INFLUENZA VACCINE - ND
Start Date09 Nov 2009 |
Sponsor / Collaborator- |
100 Clinical Results associated with Thymosin alpha 1(Beijing SL Pharmaceutical Co., Ltd.)
100 Translational Medicine associated with Thymosin alpha 1(Beijing SL Pharmaceutical Co., Ltd.)
100 Patents (Medical) associated with Thymosin alpha 1(Beijing SL Pharmaceutical Co., Ltd.)
100 Deals associated with Thymosin alpha 1(Beijing SL Pharmaceutical Co., Ltd.)